Alterity Therapeutics Stock Market Value
| ATHE Stock | USD 1.06 0.01 0.95% |
| Symbol | Alterity |
Alterity Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alterity Therapeutics. If investors know Alterity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alterity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.84) | Revenue Per Share 0.6 | Quarterly Revenue Growth 0.384 | Return On Assets (0.53) | Return On Equity (1.04) |
The market value of Alterity Therapeutics is measured differently than its book value, which is the value of Alterity that is recorded on the company's balance sheet. Investors also form their own opinion of Alterity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alterity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alterity Therapeutics' market value can be influenced by many factors that don't directly affect Alterity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alterity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alterity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alterity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Alterity Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alterity Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alterity Therapeutics.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Alterity Therapeutics on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Alterity Therapeutics or generate 0.0% return on investment in Alterity Therapeutics over 30 days. Alterity Therapeutics is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimers disease, ... More
Alterity Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alterity Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alterity Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 23.32 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 5.34 |
Alterity Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alterity Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alterity Therapeutics' standard deviation. In reality, there are many statistical measures that can use Alterity Therapeutics historical prices to predict the future Alterity Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | (0.14) |
Alterity Therapeutics Backtested Returns
Alterity Therapeutics secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of risk over the last 3 months. Alterity Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alterity Therapeutics' Mean Deviation of 2.92, standard deviation of 3.96, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.82, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alterity Therapeutics will likely underperform. At this point, Alterity Therapeutics has a negative expected return of -0.51%. Please make sure to confirm Alterity Therapeutics' day median price, period momentum indicator, as well as the relationship between the accumulation distribution and potential upside , to decide if Alterity Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.43 |
Modest reverse predictability
Alterity Therapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Alterity Therapeutics time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alterity Therapeutics price movement. The serial correlation of -0.43 indicates that just about 43.0% of current Alterity Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.43 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Alterity Therapeutics lagged returns against current returns
Autocorrelation, which is Alterity Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alterity Therapeutics' stock expected returns. We can calculate the autocorrelation of Alterity Therapeutics returns to help us make a trade decision. For example, suppose you find that Alterity Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Alterity Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alterity Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alterity Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alterity Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Alterity Therapeutics Lagged Returns
When evaluating Alterity Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alterity Therapeutics stock have on its future price. Alterity Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alterity Therapeutics autocorrelation shows the relationship between Alterity Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Alterity Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Alterity Therapeutics is a strong investment it is important to analyze Alterity Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alterity Therapeutics' future performance. For an informed investment choice regarding Alterity Stock, refer to the following important reports:Check out Alterity Therapeutics Correlation, Alterity Therapeutics Volatility and Alterity Therapeutics Alpha and Beta module to complement your research on Alterity Therapeutics. For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Alterity Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.